Literature DB >> 29383412

[Anxiety disorders: which psychotherapy for whom?]

A Ströhle1, T Fydrich2.   

Abstract

According to the Federal Healthcare Survey (Bundesgesundheitssurvey), approximately 15% of the German population fulfil the diagnostic criteria for at least one anxiety disorder within (any) 1 year. Women are affected approximately twice as often as men. The study by the Robert Koch Institute included the systematic assessment of panic disorder, agoraphobia, generalized anxiety disorder, social anxiety disorder and specific phobias; therefore, the question for both those affected and the treating therapist is "anxiety disorders: which psychotherapy for whom?" is of great clinical and healthcare political importance. We therefore review the available literature for answering three more specific questions: 1) what are the most suitable forms of psychotherapy, 2) which psychotherapy is most promising for an individual patient and diagnosis (differential evaluation of indications) and 3) what is the best approach to nonresponse or avoidance of the treatment offered? National and international guidelines agree that cognitive behavioral therapy is the psychotherapy of first choice in most patients with anxiety disorders. In cases of nonresponse or lack of availability of the appropriate therapy, psychodynamic therapy or pharmacotherapy can also be recommended. For individualized treatment recommendations we do not have empirical evidence. Also, no evidence-based (individual) recommendations are available for non-responders;however, there are some preferred strategies based on a clinical consensus.

Entities:  

Keywords:  Cognitive behavioral therapy; Differential indications; Guidelines; Nonresponse; Response prediction

Mesh:

Substances:

Year:  2018        PMID: 29383412     DOI: 10.1007/s00115-018-0481-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  20 in total

1.  Treating Treatment-Resistant Patients with Panic Disorder and Agoraphobia Using Psychotherapy: A Randomized Controlled Switching Trial.

Authors:  Andrew T Gloster; Rainer Sonntag; Jürgen Hoyer; Andrea H Meyer; Simone Heinze; Andreas Ströhle; Georg Eifert; Hans-Ulrich Wittchen
Journal:  Psychother Psychosom       Date:  2015-02-21       Impact factor: 17.659

Review 2.  Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application.

Authors:  Ulrike Lueken; Kathrin C Zierhut; Tim Hahn; Benjamin Straube; Tilo Kircher; Andreas Reif; Jan Richter; Alfons Hamm; Hans-Ulrich Wittchen; Katharina Domschke
Journal:  Neurosci Biobehav Rev       Date:  2016-05-07       Impact factor: 8.989

3.  No psychotherapy monoculture for anxiety disorders.

Authors:  Christiane Steinert; Falk Leichsenring
Journal:  Lancet       Date:  2017-05-11       Impact factor: 79.321

4.  Prediction and moderation of improvement in cognitive-behavioral and psychodynamic psychotherapy for panic disorder.

Authors:  Dianne L Chambless; Barbara Milrod; Eliora Porter; Robert Gallop; Kevin S McCarthy; Elizabeth Graf; Marie Rudden; Brian A Sharpless; Jacques P Barber
Journal:  J Consult Clin Psychol       Date:  2017-06-26

Review 5.  The state of personalized treatment for anxiety disorders: A systematic review of treatment moderators.

Authors:  Rebecca L Schneider; Joanna J Arch; Kate B Wolitzky-Taylor
Journal:  Clin Psychol Rev       Date:  2015-03-11

6.  Advancing Personalized Medicine: Application of a Novel Statistical Method to Identify Treatment Moderators in the Coordinated Anxiety Learning and Management Study.

Authors:  Andrea N Niles; Amanda G Loerinc; Jennifer L Krull; Peter Roy-Byrne; Greer Sullivan; Cathy D Sherbourne; Alexander Bystritsky; Michelle G Craske
Journal:  Behav Ther       Date:  2017-02-23

7.  Psychotherapies for Panic Disorder: A Tale of Two Sites.

Authors:  Barbara Milrod; Dianne L Chambless; Robert Gallop; Fredric N Busch; Michael Schwalberg; Kevin S McCarthy; Charles Gross; Brian A Sharpless; Andrew C Leon; Jacques P Barber
Journal:  J Clin Psychiatry       Date:  2016-07       Impact factor: 4.384

8.  [Mental disorders in the community: healthcare utilization and disability days].

Authors:  F Jacobi; M Klose; H-U Wittchen
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2004-08       Impact factor: 1.513

9.  Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH).

Authors:  Frank Jacobi; Michael Höfler; Jens Siegert; Simon Mack; Anja Gerschler; Lucie Scholl; Markus A Busch; Ulfert Hapke; Ulrike Maske; Ingeburg Seiffert; Wolfgang Gaebel; Wolfgang Maier; Michael Wagner; Jürgen Zielasek; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2014-04-11       Impact factor: 4.035

Review 10.  Machine learning, statistical learning and the future of biological research in psychiatry.

Authors:  R Iniesta; D Stahl; P McGuffin
Journal:  Psychol Med       Date:  2016-07-13       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.